A Novel Angiotensin II-Receptor Antagonist, 606A, Induces Regression of Cardiac Hypertrophy, Augments Endothelium-Dependent Relaxation and Improves Renal Function in Stroke-Prone Spontaneously Hypertensive Rats
スポンサーリンク
概要
- 論文の詳細を見る
It is well-known that cardiac hypertrophy and arterial and renal dysfunction are serious complications of hypertension. Therefore, we investigated the chronic effects of 606A (2-propyl-3-[2′(1H-tetrazole-5-yl)biphenyl-4-yl]methyl-5-acetyl-4, 5, 6, 7-tetrahydro imidazo[4, 5-c]pyridine-4-carboxylic acid disodium salt), a novel AT1-receptor antagonist, on these complications of hypertension in stroke-prone spontaneously hypertensive rats (SHRSP) using Wistar Kyoto rats (WKY) as the control. After 8 weeks treatment from 16 weeks of age with 606A by a subcutaneously implanted osmotic pump, cardiac function, cardiac weight, acetylcholine-induced endothelium-dependent relaxation in the isolated aorta and renal function were estimated. Furthermore, wall thickness of the left ventricle was studied morphologically. We found that 606A (0.3 mg, 1 mg and 3 mg/head/day) dose-dependently lowered blood pressure without any effects on heart rate in SHRSP. Long-term treatments with 606A significantly reduced cardiac weight, left ventricular wall thickness and left ventricular end diastolic pressure, whereas it did not affect cardiac contractility. Endothelium-dependent relaxation of the aorta was recovered, and total protein excretion as well as total protein excretion/creatinine excretion ratio was reduced to the level of WKY by the treatment. These results suggest that 606A not only has a hypotensive effect but also protects cardiac, renal and vascular tissues from complications of hypertension. Thus, 606A could be an useful drug for treatment of hypertension.
- 社団法人 日本薬理学会の論文
著者
-
Fushimi Keiko
Lesd Optimization Research Laboratory Tanabe Seiyaku Co. Ltd.
-
NARITA Hiroshi
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Narita Hirokazu
Research Laboratories Toyama Chemical Co. Ltd
-
Narita H
Research Laboratories Toyama Chemical Co. Ltd
-
HASHIMOTO Yoshihiro
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
KUROSAWA Yukie
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
MINAMI Koichi
Pharmaceutical Development Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
HASHIMOTO Yoshihiro
Discovery Research Laboratory, Tanabe Seiyaku Co., Ltd.
-
Kurosawa Yukie
Pharmaceutical Development Research Laboratory Tanabe Seiyaku Co. Ltd.
-
Minami Kouichiro
Department Of Anesthesiology And Critical Care Medicine Jichi Medical University
-
Hashimoto Yoshihiro
Discovery Research Laboratory Tanabe Seiyaku Co. Ltd.
関連論文
- Antithrombotic Effect of TA-993, a Novel 1,5-Benzothiazepine Derivative, in Conscious Rats
- Comparison of the Sympathetic Nervous System Activity between Spontaneously Hypertensive and Wistar-Kyoto Rats to Respond to Blood Pressure Reduction
- The Tramadol Metabolite O-Desmethyl Tramadol Inhibits Substance P–Receptor Functions Expressed in Xenopus Oocytes
- Possible Therapeutic Effect of T-794,a Novel Reversible Inhibitor of Monoamine Oxidase-A, on Post-Stroke Emotional Disturbances, Assessed in Animal Models of Depression
- Stimulation of Noradrenaline Release by T-588, a Cognitive Enhancer, in PC12 Cells
- The Effects of T-588, a Novel Cognitive Enhancer, on Noradrenaline Uptake and Release in Rat Cerebral Cortical Slices
- Cardiovascular Effects of 1,5-Benzothiazepine Derivatives Having a l-cis and d-cis Configuration in Anesthetized Dogs
- Prolongation of the Life Span of Cardiomyopathic Hamster by the Adrenergic β_1 : Selective Partial Agonist Denopamine
- A Novel Angiotensin II-Receptor Antagonist, 606A, Induces Regression of Cardiac Hypertrophy, Augments Endothelium-Dependent Relaxation and Improves Renal Function in Stroke-Prone Spontaneously Hypertensive Rats
- Cardioprotective Effects of an Angiotensin-Converting-Enzyme Inhibitor,Imidapril, and Ca2+ Channel Antagonist, Amlodipine, in Spontaneously Hypertensive Rats at Established Stage of Hypertension
- Analysis of the Effects of Anesthetics and Ethanol on μ-Opioid Receptor
- A Novel Na^+ and Ca^ Channel Blocker, T-477, Prevents Brain Edema Following Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Time-Dependent Changes in the Ischemic Forebrain Following the Microsphere-Induced Permanent Occlusion of Cerebral Arterioles in Rats
- Adrenomedullin Inhibits the Pressor Effects and Decrease in Renal Blood Flow Induced by Norepinephrine or Angiotensin II in Anesthetized Rats
- Pharmacological Aspects of the Effects of Tramadol on G-Protein Coupled Receptors
- General anesthesia for progressive external ophthalmoplegia syndrome
- Comparative Study of TA-606, a Novel Angiotensin II Receptor Antagonist, With Losartan in Terms of Species Difference and Orthostatic Hypotension
- Ischemia-Reperfusion Induced Elevation of Diastolic Tension in the Isolated Guinea Pig Heart and the Effects of Calcium Antagonists
- Combined spinal-epidural anesthesia for cesarean section in a patient with Takayasu arteritis complicated by heart failure
- Effects of sevoflurane on voltage-gated sodium channel Na_v1.8, Na_v1.7, and Na_v1.4 expressed in Xenopus oocytes
- The Tramadol Metabolite O-Desmethyl Tramadol Inhibits Substance P-Receptor Functions Expressed in Xenopus Oocytes
- Reduction of the Mortality Rate by Imidapril in a Small Coronary Artery Disease Model, (NZW*BXSB)F1 Male Mice.